|
May 1
|
Cytokinetics (CYTK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
|
|
Apr 29
|
Cytokinetics to Host Investor Event and Conference Call to Discuss the Primary Results From SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress
|
|
Apr 24
|
Cytokinetics to Announce First Quarter Results on May 8, 2024
|
|
Apr 10
|
This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?
|
|
Apr 10
|
Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress
|
|
Apr 9
|
EVP Research & Development Fady Malik Sells Shares of Cytokinetics Inc (CYTK)
|
|
Apr 5
|
Cytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Study of Aficamten, at The American College of Cardiology 73ʳᵈ Annual Scientific Session
|
|
Apr 1
|
Cytokinetics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
|
|
Mar 25
|
Cytokinetics Announces Four Upcoming Presentations at the American College of Cardiology 73rd Annual Scientific Session
|
|
Mar 20
|
2 Incredible Growth Stocks to Buy Right Now
|
|
Mar 17
|
30 Biggest Biotechnology Companies in the World
|
|
Mar 13
|
7 Biotech Stocks to Buy as Sector Rotation Ramps Up
|
|
Mar 12
|
Q4 2023 CytomX Therapeutics Inc Earnings Call
|
|
Mar 4
|
Cytokinetics to Participate in March Investor Conferences
|
|
Jan 12
|
Today’s Stock Market Movers: JPMorgan, Bank of America, Citigroup, Delta, United, UnitedHealth, Tesla, and More
|
|
Jan 12
|
Cytokinetics (CYTK) Down on Report of Novartis Not Interested
|
|
Jan 11
|
Novartis Retreats From Cytokinetics Deal, Dashing Hopes For Multi-Billion Dollar Acquisition
|
|
Jan 11
|
Cytokinetics, Albertsons, Kroger, Boeing: Trending tickers
|
|
Jan 11
|
Cytokinetics Stock Drops After Journal Report That Novartis Deal Might Be Off
|
|
Jan 11
|
UPDATE 1-Novartis drops pursuit of Cytokinetics - WSJ
|